Gal1‐induced TAMs recruited CD4+CD25+Foxp3+CCR6+ Tregs through the CCL20‐CCR6 axis and culminated in impaired anti‐tumor immune responses in HCC. This evidence concerns the gene CCL20 and hepatocellular carcinoma.